Cargando…
The Role of the Surgeon in the Germline Testing of the Newly Diagnosed Breast Cancer Patient
For patients with newly diagnosed breast cancer, information regarding hereditary predisposition can influence treatment decisions. From a surgical standpoint, patients with known germline mutations may alter decisions of local therapy to reduce the risk of second breast primaries. This information...
Autores principales: | Schick, Stephanie, Manghelli, Joshua, Ludwig, Kandice K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217718/ https://www.ncbi.nlm.nih.gov/pubmed/37232811 http://dx.doi.org/10.3390/curroncol30050353 |
Ejemplares similares
-
Patient Experience Ratings: What Do Breast Surgery Patients Care About?
por: Fan, Betty, et al.
Publicado: (2022) -
BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer
por: Nilsson, Martin P., et al.
Publicado: (2017) -
Obtaining informed consent for clinical tumor and germline exome sequencing of newly diagnosed childhood cancer patients
por: Scollon, Sarah, et al.
Publicado: (2014) -
Breast Magnetic Resonance Imaging for Patients With Newly Diagnosed Breast Cancer: A Review
por: Kim, Soo-Yeon, et al.
Publicado: (2022) -
Indicators of distress in newly diagnosed breast cancer patients
por: Chirico, Andrea, et al.
Publicado: (2015)